COVID vaccine efficacy wanes, but jabs offer protection: Study
3 years, 4 months ago

COVID vaccine efficacy wanes, but jabs offer protection: Study

Al Jazeera  

Oxford University researchers say efficacy of Pfizer, AstraZeneca weakens 90 days after second dose, but both ‘still doing really well against Delta’ strain. The efficacy of two widely used coronavirus vaccines against the Delta variant weakens within three months of inoculation, but the jabs remain the most effective way to ensure protection against the strain, Oxford University researchers have found. Two doses of the Pfizer and AstraZeneca vaccines provide protection levels of up to 75 and 61 percent respectively, 90 days after inoculation, they said in the largest study of its kind, published on Thursday. “Both of these vaccines, at two doses, are still doing really well against Delta … When you start very, very high, you got a long way to go,” said Sarah Walker, an Oxford University professor of medical statistics and the survey’s chief investigator.

Protection Vaccines Month Delta Vaccine Oxford Vaccinated Pfizer Oxford University  variant  researchers  offer  delta  vaccinated  wanes  jabs  efficacy  oxford  month  vaccines  vaccine  study  covid  protection

History of this topic

AstraZeneca pulls its COVID-19 vaccine from the European market
7 months, 2 weeks ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
7 months, 2 weeks ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
7 months, 2 weeks ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
7 months, 3 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

'Defences tend to fade over time': US health agency recommends older to get another COVID shot this spring
9 months, 3 weeks ago

'Defences tend to fade over time': US health agency recommends older to get another COVID shot this spring

India TV News  

Washington: Older US adults should roll up their sleeves for another COVID-19 shot, even if they got a booster in the fall, an influential government advisory panel said on Wednesday. The panel voted 11-1 to say Americans 65 and older should get another dose of the updated vaccine that became available in September — if at least four months have …

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise
1 year ago

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise

Daily Mail  

New COVID-19 vaccines targeting the current Omicron variant of the virus are available in community pharmacies throughout Australia. Pharmacy Guild of Australia National President Trent Twomey says the new vaccine available on Monday is targeted at the strain of the virus which is currently circulating among the population. 'With COVID-19 cases on the rise, it is important anyone who is …

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case
1 year, 1 month ago

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case

The Telegraph  

As many as 80 claimants could lodge legal cases with the High Court by the end of the year in a class action that threatens to undermine faith in the rollout of the AstraZeneca vaccine that was developed jointly with Oxford University. In Mr Scott’s claim, his lawyers argue that he suffered “personal injuries and consequential losses arising out of …

Pre-Covid shots provided 60% protection against post-infection deaths: Study
1 year, 4 months ago

Pre-Covid shots provided 60% protection against post-infection deaths: Study

India Today  

The Indian Council of Medical Research, which studied the cause of death in people after recovering from Covid-19 infection, found that those who were vaccinated before contracting the virus had 60 per cent protection against post-discharge mortality. An expert team working at the National Clinical Registry for Covid evaluated factors related to post-discharge mortality during the first year after Covid, …

As COVID-19 spikes in California, booster shots could make all the difference
2 years ago

As COVID-19 spikes in California, booster shots could make all the difference

LA Times  

With coronavirus cases and hospitalizations rising in Los Angeles County, officials are voicing new confidence in the effectiveness of the updated COVID-19 booster shot. New data has found that the updated COVID-19 vaccines offer “significant additional protection” against symptomatic infection in people who were previously vaccinated or boosted with the older formula. “We have seen very low uptake of the …

COVID-19 vaccines offer significant protection against reinfection: Study
2 years, 1 month ago

COVID-19 vaccines offer significant protection against reinfection: Study

India TV News  

COVID-19 vaccine: A recent study revealed that people earlier infected with the SARS-CoV-2 virus still benefit from vaccination against COVID-19, gaining 60% to 94% protection against reinfection. “In our study, we find a significant vaccine effectiveness against SARS-CoV-2 reinfection, and this shows the importance of vaccination also for those who might be protected by natural immunity," said Katrine Finderup Nielsen …

Study confirms AstraZeneca jab’s higher risk of very rare clot
2 years, 1 month ago

Study confirms AstraZeneca jab’s higher risk of very rare clot

The Hindu  

AstraZeneca's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that -- in a tiny number of cases -- thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study
2 years, 1 month ago

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study

News 18  

AstraZeneca’s Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that — in a tiny number of cases — thrombosis with thrombocytopenia syndrome can be a possible side effect …

Repeat covid vaccinations opened to all as postive tests mount
2 years, 2 months ago

Repeat covid vaccinations opened to all as postive tests mount

Dutch News  

Everyone over the age of 12 is now being invited to sign up for another coronavirus vaccination, the health ministry has confirmed. With covid infections once again on the rise, health officials say getting the top-up jabs will help slow the spread of the virus. People aged 40 to 60 can make an appointment via website planjeprik.nl next week, while …

Repeat covid vaccinations opened to all as postive tests mount
2 years, 2 months ago

Repeat covid vaccinations opened to all as postive tests mount

Dutch News  

Everyone over the age of 12 is now being invited to sign up for another coronavirus vaccination, the health ministry has confirmed. With covid infections once again on the rise, health officials say getting the top-up jabs will help slow the spread of the virus. People aged 40 to 60 can make an appointment via website planjeprik.nl next week, while …

New vaccines approved, booster campaign to start in September
2 years, 3 months ago

New vaccines approved, booster campaign to start in September

Dutch News  

The new Pfizer and Moderna booster vaccines have been given approval by the European Medicines Agency for over-12s, and another booster campaign is planned for the second half of September. Although the current vaccines protect against serious sickness, they have become less good at protecting against a coronavirus infection due to mutations in the virus, reports NOS. The EMA expects …

New vaccines approved, booster campaign to start in September
2 years, 3 months ago

New vaccines approved, booster campaign to start in September

Dutch News  

The new Pfizer and Moderna booster vaccines have been given approval by the European Medicines Agency for over-12s, and another booster campaign is planned for the second half of September. Although the current vaccines protect against serious sickness, they have become less good at protecting against a coronavirus infection due to mutations in the virus, reports NOS. The EMA expects …

Tweaked COVID boosters close but how much will they help?
2 years, 3 months ago

Tweaked COVID boosters close but how much will they help?

Associated Press  

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but still up in the air is how much benefit the booster shots will offer, who should get one -- and how soon. Dr. Peter Marks, the FDA’s vaccine chief, said Thursday that once authorized, the tweaked boosters could help right away …

Covid vaccine effectiveness falls to 0% a year after first series
2 years, 5 months ago

Covid vaccine effectiveness falls to 0% a year after first series

NL Times  

People who have only received the first and second vaccine shots against Covid-19 are barely protected against a coronavirus infection one year after the injections. By that time, vaccine effectiveness falls to 0 percent, according to the RIVM, the Dutch public health institute. Those who received a booster shot in the interim still receive protection against serious symptoms of the …

Gap Between 2nd Covid Vaccine, Booster Dose Reduced To 3 Months For Those Travelling Abroad
2 years, 7 months ago

Gap Between 2nd Covid Vaccine, Booster Dose Reduced To 3 Months For Those Travelling Abroad

ABP News  

New Delhi: The government has now reduced the gap between second Covid-19 vaccine jab and booster dose to a minimum of 90 days for those travelling abroad, news agency PTI reported quoting official sources on Wednesday. Those who need to travel overseas can take the booster dose of Covid vaccine as required by the country they are travelling to before …

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study
2 years, 7 months ago

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study

India TV News  

A fourth dose of the Pfizer or Moderna COVID-19 vaccine is safe and boosts antibody levels, even higher than that of a third dose, according to the latest results from a nationwide study in the UK. The findings, published in The Lancet Infectious Disease journal, show that fourth dose mRNA booster vaccines for COVID-19 are well-tolerated in people who received …

New oral Covid vaccine can decrease severity, transmission: Study
2 years, 7 months ago

New oral Covid vaccine can decrease severity, transmission: Study

India Today  

An investigational Covid vaccine designed to be administered orally has not only limited the degree of the disease but also decreased its airborne spread during its trial on animals, revealed a study published in the journal, Science Translational Medicine, earlier this week. The research team led by Duke University researcher Stephanie N Langel, a medical instructor in the Department of …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 7 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

Covid-19: US FDA approves another Pfizer, Moderna booster dose for age 50 and up
2 years, 8 months ago

Covid-19: US FDA approves another Pfizer, Moderna booster dose for age 50 and up

India Today  

US regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds. The Food and Drug Administration's decision opens a fourth dose of the Pfizer or Moderna vaccines to those people at least four months after their previous booster. Pfizer had asked the …

EU regulator advises AstraZeneca’s COVID drug be cleared
2 years, 9 months ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press  

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

EU Drug Watchdog Approves AstraZeneca Covid Prevention Jab 'Evusheld'
2 years, 9 months ago

EU Drug Watchdog Approves AstraZeneca Covid Prevention Jab 'Evusheld'

News 18  

The EU’s drug watchdog on Thursday recommended for approval AstraZeneca’s Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines. The European Medicines Agency’s human medicines committee “has recommended granting a marketing authorisation for Evusheld, developed by AstraZeneca for the prevention of Covid-19 in adults and adolescents from 12 years …

AstraZeneca set to abandon push for US vaccine approval
2 years, 9 months ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

Coronavirus updates March 04, 2022
2 years, 9 months ago

Coronavirus updates March 04, 2022

The Hindu  

In 2022, 92% of COVID deaths have been in unvaccinated individuals, Director General of the Indian Council of Medical Research Dr. Balram Bhargava said on Thursday. Here are the latest updates Study Third Covid vaccine dose advised for immunocompromised people: study A third dose of the COVID-19 vaccine is recommended for people with a weakened immune system, especially for organ …

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients
2 years, 9 months ago

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients

Daily Mail  

The Johnson & Johnson COVID-19 vaccine was not nearly as effective as its peers at preventing hospitalization from the virus, a new study of elderly patients finds. A French research team found that 28 days after administration of the single-dose J&J shot, and the second dose of the Pfizer-BioNTech vaccine, the J&J recipients were 5.2 times more likely to be …

Pfizer vaccine less effective against Covid19 in kids aged 5-11: Study
2 years, 9 months ago

Pfizer vaccine less effective against Covid19 in kids aged 5-11: Study

India TV News  

Highlights The effectiveness of the Pfizer vaccine for children waned quickly during the Omicron surge in US Effectiveness against hospitalisation in children from age 5 to 11 dropped substantially dropped Vaccine effectiveness fell more slowly for smaller children as it did for older children The effectiveness of the Pfizer COVID-19 vaccine for children waned quickly during the Omicron surge in …

Pfizer Covid-19 vaccine effectiveness fell quickly for kids during Omicron surge but still offered some protection against severe diseae
2 years, 9 months ago

Pfizer Covid-19 vaccine effectiveness fell quickly for kids during Omicron surge but still offered some protection against severe diseae

CNN  

CNN — The effectiveness of the Pfizer/BioNTech Covid-19 vaccines for children waned quickly during the Omicron surge, especially among children ages 5 to 11, but was still protective against severe disease, according to new data from the New York State Department of Health. “The data are not surprising as the vaccine was developed in response to an earlier COVID-19 variant …

COVID: New protein-based vaccine up for approval
2 years, 10 months ago

COVID: New protein-based vaccine up for approval

The Hindu  

Sanofi and GlaxoSmithKline are seeking E.U. and U.S. regulatory approval of their protein-based COVID-19 vaccine, which proved 100 per cent effective at preventing severe illness in phase three clinical trials, the duo announced on Wednesday. Official trial results are yet to be published, but the companies reported that in phase three testing, two doses of the vaccine showed 100 per …

Three doses of Pfizer Covid vaccine better than two: Study
2 years, 10 months ago

Three doses of Pfizer Covid vaccine better than two: Study

Deccan Chronicle  

Washington: A third dose of the Pfizer COVID-19 vaccine conferred higher effectiveness against infection and hospitalisation than two doses of the preventive after one month, a study has found. "When we looked at the effectiveness of the two doses of Pfizer–BioNTech vaccine versus three doses, we see a benefit with three doses that exceeds that achieved with two doses alone," …

Covid Booster Efficacy Wanes Significantly by Fourth Month: US Study
2 years, 10 months ago

Covid Booster Efficacy Wanes Significantly by Fourth Month: US Study

News 18  

The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention said Friday. During the Omicron-predominant period, vaccine efficacy against Covid-associated emergency department or urgent care visits was 87 percent during the two months after a third dose, but …

Study: COVID booster effectiveness wanes but remains strong
2 years, 10 months ago

Study: COVID booster effectiveness wanes but remains strong

LA Times  

A CDC report looking at the durability of booster protection during the Omicron wave found that protection wanes but remains strong. An early look at the performance of COVID-19 booster shots during the Omicron wave in the U.S. hinted at a decline in effectiveness, though the shots still offered strong protection against severe illness. But researchers also found that during …

Vaccine protection better maintained against severe COVID-19: Lancet study
2 years, 10 months ago

Vaccine protection better maintained against severe COVID-19: Lancet study

Firstpost  

The results showed that protection against infection of any severity waned progressively following the peak which occurred a month after the second dose London: The vaccine-induced protection against SARS-CoV-2 infection wanes within a few months, but protection against severe COVID-19 appears to be better maintained, according to a study published in The Lancet journal. “The bad news is that the …

Vaccine protection better maintained against severe Covid-19: Lancet study
2 years, 10 months ago

Vaccine protection better maintained against severe Covid-19: Lancet study

India Today  

The vaccine-induced protection against SARS-CoV-2 infection wanes within a few months, but protection against severe COVID-19 appears to be better maintained, according to a study published in The Lancet journal. "The bad news is that the protection against infection seems to be diminished by seven months after the second dose of vaccine," said Peter Nordstrom, a professor at Umea University …

Vaccine protection better maintained against severe COVID-19: Lancet study
2 years, 10 months ago

Vaccine protection better maintained against severe COVID-19: Lancet study

Deccan Chronicle  

London: The vaccine-induced protection against SARS-CoV-2 infection wanes within a few months, but protection against severe COVID-19 appears to be better maintained, according to a study published in The Lancet journal. "The bad news is that the protection against infection seems to be diminished by seven months after the second dose of vaccine," said Peter Nordstrom, a professor at Umea …

Pfizer asks US to authorise COVID jabs for children under age 5
2 years, 10 months ago

Pfizer asks US to authorise COVID jabs for children under age 5

Al Jazeera  

The nation’s 19 million children under 5 are the only group not yet eligible for vaccination against the coronavirus. US pharmaceutical company Pfizer has asked the United States to authorise extra-low doses of its COVID-19 vaccine for children under age five, potentially opening the way for the very youngest Americans to start receiving shots as early as March. The nation’s …

When parents are vaccinated against COVID-19, protection extends to their kids
2 years, 10 months ago

When parents are vaccinated against COVID-19, protection extends to their kids

LA Times  

Monserat Ramos watches as her grandparent receives a COVID-19 vaccine at a clinic in South Los Angeles. In two very different phases of the pandemic, the research shows that children’s health relied heavily on indirect vaccine effects: For starters, vaccinated parents were less likely to bring the coronavirus into the household. During last winter’s wave of infections involving the Alpha …

Can vaccination reduce long effects of Covid-19? Here's what we know
2 years, 10 months ago

Can vaccination reduce long effects of Covid-19? Here's what we know

Hindustan Times  

Vaccination can help reduce the long effects of Covid-19 infection, researchers have found based on data collected from those infected with coronavirus. An Israeli report has surfaced that shows that people vaccinated with both doses of the Pfizer-BioNTech vaccine were much less likely to report long Covid as compared to those unvaccinated. The term ‘long Covid’ refers to a condition …

Booster jab offers considerable protection against hospital, RIVM says
2 years, 11 months ago

Booster jab offers considerable protection against hospital, RIVM says

Dutch News  

Booster injections are extremely effective at preventing hospitalisations for coronavirus, says Dutch public health institute RIVM, after studying hospital figures over a two month period. The RIVM researchers said someone who had a booster had a five times lower chance of being admitted to hospital than someone who has been vaccinated, but not yet a third jab. The vaccine effectiveness …

Booster jab offers considerable protection against hospital, RIVM says
2 years, 11 months ago

Booster jab offers considerable protection against hospital, RIVM says

Dutch News  

Booster injections are extremely effective at preventing hospitalisations for coronavirus, says Dutch public health institute RIVM, after studying hospital figures over a two month period. The RIVM researchers said someone who had a booster had a five times lower chance of being admitted to hospital than someone who has been vaccinated, but not yet a third jab. The vaccine effectiveness …

COVID19 vaccines offer lasting protection, claims study
2 years, 11 months ago

COVID19 vaccines offer lasting protection, claims study

India TV News  

New research has found that COVID vaccination offers long-lasting protection from the worst outcomes of infection. The study found that the effectiveness of the Pfizer and Moderna mRNA vaccines in reducing the risk of COVID-19 reached a peak of about 95 per cent two months after the first dose and then gradually declined. At seven months, the Pfizer vaccine dropped …

COVID-19 vaccines offer lasting protection, claims study
2 years, 11 months ago

COVID-19 vaccines offer lasting protection, claims study

India TV News  

A new research has found that COVID-19 vaccination offers long-lasting protection from the worst outcomes of COVID-19. "This is an excellent example of the wonderful research partnership between the Gillings School and NCDHHS, who are working together to generate the evidence base needed to keep our communities safe," said Penny Gordon-Larsen, PhD, Carla Smith Chamblee Distinguished Professor of Global Nutrition …

Booster longevity: Data reveals how long a third shot protects
2 years, 11 months ago

Booster longevity: Data reveals how long a third shot protects

NPR  

Booster longevity: Data reveals how long a third shot protects Enlarge this image toggle caption Dimas Ardian/Bloomberg via Getty Images Dimas Ardian/Bloomberg via Getty Images We've known for about a month now that a third shot of the vaccine is critical for protecting against infection with the omicron variant — and for keeping people out of the hospital. Protection against …

2 Vaccine Doses, Previous Infection May Protect Against Covid for a Year: Study
2 years, 11 months ago

2 Vaccine Doses, Previous Infection May Protect Against Covid for a Year: Study

News 18  

Many wonder how much of an impact the vaccine has had on the Covid-19. According to new research, a person who has previously had Covid and has had two doses of the vaccine, will have 90 percent protection against the virus for an additional year. According to the research, the best strategy to guard against future Covid infection is to …

Study finds fourth dose of Covid vaccine boosts antibodies five-fold
2 years, 11 months ago

Study finds fourth dose of Covid vaccine boosts antibodies five-fold

Live Mint  

A fourth dose of Covid-19 vaccine boosts antibodies fivefold a week after the shot is administered, Israeli Prime Minister Naftali Bennett said on Tuesday, citing preliminary findings of an Israeli study. Israel has already announced it will administer a fourth dose of coronavirus vaccine to people over the age of 60 and medical personnel, becoming the first nation in the …

Israeli study shows five-fold antibody rise with fourth COVID jab
2 years, 11 months ago

Israeli study shows five-fold antibody rise with fourth COVID jab

Al Jazeera  

A fourth dose of COVID-19 vaccine boosts antibodies five-fold a week after the shot is administered, Israeli Prime Minister Naftali Bennett has said, citing preliminary findings of an Israeli study. “A week into the fourth dose we know to a higher degree of certainty that the fourth dose is safe,” Bennett said at Sheba Medical Center, which is giving second …

US authorizes Pfizer booster for kids as young as 12
2 years, 11 months ago

US authorizes Pfizer booster for kids as young as 12

Raw Story  

US health authorities on Monday approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages. The FDA also approved a booster dose of Pfizer-BioNTech's vaccine for immunocompromised children between the ages of five and 11, including for example individuals …

As COVID's Omicron variant surges, do over 60s who got the AstraZeneca vaccine need a booster sooner?
3 years ago

As COVID's Omicron variant surges, do over 60s who got the AstraZeneca vaccine need a booster sooner?

ABC  

Linda Fisher and her husband Ken are members of Generation AZ: the group of those aged 60+ who lined up for an AstraZeneca vaccine, the only one available to their age group for some time. "If Omicron didn't exist you would probably feel pretty relaxed around Christmas this year," he says. "Most people have a certain degree of immunity which …

Discover Related